Press release
Metastatic Liver Cancer Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers
Request a sample and discover the recent advances in Metastatic Liver Cancer Treatment Drugs @ Metastatic Liver Cancer Pipeline Outlook [https://www.delveinsight.com/sample-request/metastatic-liver-cancer-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Metastatic Liver Cancer Pipeline Report
* In October 2024: HepaRegeniX GmbH- The goal of this clinical trial is to learn if HRX215 is safe and tolerable in adults who have undergone surgical removal of metastatic tumor(s) due to colorectal carcinoma in the liver.
* In October 2024:- DualityBio Inc.- A Phase 1/2a, Multicenter, Open-Label, First in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of DB-1303/BNT323 in Patients with Advanced/Metastatic Solid Tumors. This is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1303/BNT323 in subjects with advanced solid tumors that express HER2.
* DelveInsight's Metastatic Liver Cancer pipeline report depicts a robust space with 20+ active players working to develop 25+ pipeline therapies for Metastatic Liver Cancer treatment.
* The leading Metastatic Liver Cancer Companies such as Oncorus, Sirnaomics, Codiak BioSciences, Sorrento Therapeutics, Inc., RemeGen Co., Ltd., Taiho Pharmaceutical Co., Ltd., Amarin Corporation, Eureka Therapeutics, Medivir AB, AstraZeneca, Amal Therapeutics, Boehringer Ingelheim , and others.
* Promising Metastatic Liver Cancer Therapies such as ThermoDox Registered (LTLD), NV1020, Combretastatin A1 Diphosphate (OXi4503), Talaporfin sodium (LS11), CRS-100, EndoTAG Registered -1, AV-299, RO7119929, Tocilizumab , and others.
Find out more about Metastatic Liver Cancer Therapeutics Assessment @ Metastatic Liver Cancer Preclinical and Discovery Stage Products [https://www.delveinsight.com/sample-request/metastatic-liver-cancer-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Metastatic Liver Cancer Emerging Drugs Profile
* exoASO STAT6: Codiak BioSciences
exoASO Trademark -STAT6 is an exosome therapeutic candidate engineered using our engEx Trademark Platform to overexpress Codiak's novel protein scaffold, PTGFRN, to selectively target uptake in M2 polarized tumor-associated macrophages. Currently the drug is in Phase I stage of Clinical trial evaluation for the treatment of Metastatic-Liver-Cancer.
* STP 705: Sirnaomics
STP705, is a dual TGF-Ss1/COX-2 inhibitor. TGF-Ss1 and COX-2 are well-validated gatekeeper targets for oncology and fibrosis disease drug development. STP705 leverages our locally administered PNP formulation for direct administration to diseased tissue. STP705 has received U.S. orphan drug designation for the treatment of certain hepatocellular carcinomas and liver fibrosis, including: primary sclerosing cholangitis (PSC), cholangiocarcinoma (CCA) and hepatocellular carcinoma (HCC). Currently the drug is in Phase I stage of Clinical trial evaluation for the treatment of Metastatic-Liver-Cancer.
* ONCR 177: Oncorus
ONCR-177, our lead product candidate, is an intratumorally administered Herpes Simplex Virus (HSV) viral immunotherapy for the treatment of multiple solid tumor cancers. ONCR-177 fights tumors through multiple mechanisms, including inherent oncolytic activity, immune stimulation elicited by viral infection and the expression of five transgenes (IL-12, CCL4, FLT3LG, anti-PD-1 and anti-CTLA-4). Currently the drug is in Phase I stage of Clinical trial evaluation for the treatment of Metastatic-Liver-Cancer.
Explore groundbreaking therapies and clinical trials in the Metastatic Liver Cancer Pipeline. Access DelveInsight's detailed report now! @ New Metastatic Liver Cancer Drugs [https://www.delveinsight.com/sample-request/metastatic-liver-cancer-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Metastatic-Liver-Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration
* Intra-articular
* Intraocular
* Intrathecal
* Intravenous
* Ophthalmic
* Oral
* Parenteral
* Subcutaneous
* Topical
* Transdermal
Metastatic Liver Cancer Products have been categorized under various Molecule types such as
* Oligonucleotide
* Peptide
* Small molecule
Unveil the future of Metastatic Liver Cancer Treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight's expert analysis @ Metastatic Liver Cancer Market Drivers and Barriers [https://www.delveinsight.com/sample-request/metastatic-liver-cancer-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Metastatic Liver Cancer Pipeline Report
* Coverage- Global
* Metastatic Liver Cancer Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
* Metastatic Liver Cancer Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
* Metastatic Liver Cancer Companies- Oncorus, Sirnaomics, Codiak BioSciences, Sorrento Therapeutics, Inc., RemeGen Co., Ltd., Taiho Pharmaceutical Co., Ltd., Amarin Corporation, Eureka Therapeutics, Medivir AB, AstraZeneca, Amal Therapeutics, Boehringer Ingelheim, and others.
* Metastatic Liver Cancer Therapies- ThermoDox Registered (LTLD), NV1020, Combretastatin A1 Diphosphate (OXi4503), Talaporfin sodium (LS11), CRS-100, EndoTAG Registered -1, AV-299, RO7119929, Tocilizumab, and others.
Get the latest on Metastatic Liver Cancer Therapies and clinical trials. Download DelveInsight's in-depth pipeline report today! @ Metastatic Liver Cancer Companies, Key Products and Unmet Needs [https://www.delveinsight.com/sample-request/metastatic-liver-cancer-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
* Introduction
* Executive Summary
* Metastatic-Liver-Cancer: Overview
* Pipeline Therapeutics
* Therapeutic Assessment
* Metastatic-Liver-Cancer- DelveInsight's Analytical Perspective
* Late Stage Products (Phase III)
* Drug name :Company Name
* Drug profiles in the detailed report.....
* Mid Stage Products (Phase II)
* Drug name :Company Name
* Drug profiles in the detailed report.....
* Early Stage Products (Phase I)
* ONCR 177: Oncorus
* Drug profiles in the detailed report.....
* Preclinical and Discovery Stage Products
* Drug name :Company Name
* Drug profiles in the detailed report.....
* Inactive Products
* Metastatic-Liver-Cancer Key Companies
* Metastatic-Liver-Cancer Key Products
* Metastatic-Liver-Cancer- Unmet Needs
* Metastatic-Liver-Cancer- Market Drivers and Barriers
* Metastatic-Liver-Cancer- Future Perspectives and Conclusion
* Metastatic-Liver-Cancer Analyst Views
* Metastatic-Liver-Cancer Key Companies
* Appendix
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=metastatic-liver-cancer-pipeline-therapeutics-assessment-companies-products-unmet-needs-market-drivers-and-barriers]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Metastatic Liver Cancer Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers here
News-ID: 3697024 • Views: …
More Releases from ABNewswire
Jacksonville Company Introduces Specialized Pressure Washing Program for Concret …
Nubirth Pressure Washing launches a specialized program for concrete and roof cleaning across Jacksonville, using eco-friendly methods and soft-wash techniques tailored to Florida's climate.
A Jacksonville-based property maintenance company has launched a specialized service program focused on concrete and roofing surfaces, responding to increased demand for professional exterior care across Northeast Florida. Nubirth Pressure Washing [http://index.businessinsurance.com/businessinsurance/article/abnewswire-2025-8-30-jacksonville-family-business-expands-concrete-washing-services-amid-growing-property-maintenance-demand], operating since 2004, has developed targeted methods to address the region's unique climate challenges affecting…
Coolidge Pest Control Services Provider Reports 70% Reduction in Repeat Infestat …
Executive Pest Solutions documents 70% fewer repeat infestations using exclusion methods that seal entry points before treating pest problems in Coolidge properties.
A Coolidge-based company has documented significant results in preventing recurring pest problems through a preventative approach that prioritizes blocking entry points rather than reactive treatments. Executive Pest Solutions [http://index.businessinsurance.com/businessinsurance/article/abnewswire-2025-8-30-executive-pest-controls-bug-exterminators-issue-early-warning-for-arizona-homeowners-as-monsoon-season-triggers-200-surge-in-snake-and-rodent-activity] recently released data showing a 70% reduction in repeat infestations among clients who received exclusion-focused pest control services [https://www.google.com/maps/place/Executive+Pest+Solutions/@32.9674597,-111.5377949,2026m/data=!3m1!1e3!4m10!1m2!2m1!1spest+control+services+coolidge!3m6!1s0x872a41f2968fecad:0x4473a5ec9b393e0d!8m2!3d32.9685083!4d-111.5416582!15sCh5wZXN0IGNvbnRyb2wgc2VydmljZXMgY29vbGlkZ2VaICIecGVzdCBjb250cm9sIHNlcnZpY2VzIGNvb2xpZGdlkgEUcGVzdF9jb250cm9sX3NlcnZpY2WaASRDaGREU1VoTk1HOW5TMFZKUTBGblNVTnVYemhpY2paQlJSQUKqAXgKCS9tLzAzaGxkZAoJL20vMDFkcWtjEAEqGSIVcGVzdCBjb250cm9sIHNlcnZpY2VzKAAyHxABIhsztxY3DkC8S93Vj7kS2ZKl3yJaoCjC-bPproIyIhACIh5wZXN0IGNvbnRyb2wgc2VydmljZXMgY29vbGlkZ2XgAQD6AQQIABBG!16s%2Fg%2F11vl3cr51p!5m1!1e3?entry=ttu], marking…
Prime Construction & Remodeling Streamlines Bathroom Remodeling in Austin to Red …
Prime Construction & Remodeling cuts bathroom renovation timelines by 20-30% through improved scheduling, material management, and specialized crews while maintaining quality standards across Austin and Central Texas.
Austin homeowners facing lengthy renovation timelines can now achieve faster project completion without sacrificing quality. Prime Construction & Remodeling [http://index.businessinsurance.com/businessinsurance/article/abnewswire-2025-8-30-prime-construction-and-remodeling-introduces-eco-conscious-bathroom-remodeling-in-austin-tx-to-meet-rising-demand-for-sustainable-home-upgrades] has implemented new operational protocols that significantly reduce the duration of bathroom remodeling in Austin [https://www.google.com/localservices/prolist?src=2&q=bathroom%20remodeling%20austin&ved=2ahUKEwil6tbmlN2QAxWllCkDHQRUIXMQjdcJegQIABAF&slp=MgBAAVIECAIgAIgBAA%3D%3D&spp=Cg0vZy8xMWxjbDAyOGR6OsgBV2lBUUFCQUJJaHBpWVhSb2NtOXZiU0J5WlcxdlpHVnNhVzVuSUdGMWMzUnBicW9CY0FvSkwyMHZNREZxTW1KcUNnY3ZiUzh3ZG5wdEVBRXFGeUlUWW1GMGFISnZiMjBnY21WdGIyUmxiR2x1WnlnQU1oOFFBU0lid0ltenBRWE50dm5uSEUxeDNEMWg2d3NfSW9zZkp0VHhlUFpDTWg0UUFpSWFZbUYwYUhKdmIyMGdjbVZ0YjJSbGJHbHVaeUJoZFhOMGFXND0%3D&scp=CgpnY2lkOnN0b3JlEgAaACoFU3RvcmU6AkAB], TX projects, addressing one of the most common…
Collaborative Design Studio Raises Landscape Lighting Quality Standards Through …
Denver-based lighting firm operates a collaborative design studio that connects AOLP-certified professionals across regional markets, maintaining consistent quality standards through mentorship and shared expertise.
A professional design studio model is changing how outdoor lighting projects are delivered across multiple markets. Lighthouse Outdoor Lighting and Audio of Denver [http://index.businessinsurance.com/businessinsurance/article/abnewswire-2025-9-29-aolp-certified-lighting-professionals-report-40-surge-in-holiday-lighting-installation-bookings-as-safety-awareness-grows] has established a centralized design studio that connects certified lighting professionals across regional offices, creating a collaborative framework that maintains consistent quality standards…
More Releases for Metastatic
Key Trends Reshaping the Metastatic Bone Disease Market: Advancements in Targete …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Metastatic Bone Disease Market Size Growth Forecast: What to Expect by 2025?
The market size for metastatic bone disease has seen a quick expansion in the past few years. This market will increase from a value of $17.14 billion in 2024 to $18.88 billion in 2025, with a compound…
Emerging Trends Influencing The Growth Of The Metastatic Urothelial Carcinoma Ma …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
How Big Is the Metastatic Urothelial Carcinoma Market Size Expected to Be by 2034?
The market size for metastatic urothelial carcinoma has seen exponential growth recently. The market will expand from a worth of $1.18 billion in 2024 to $1.42 billion in 2025, with a compound annual growth rate (CAGR) of 20.2%.…
Key Influencer in the Metastatic Cancer Drugs Market 2025: Surging Prevalence Of …
How Are the key drivers contributing to the expansion of the metastatic cancer drugs market?
The escalation in the incidence of metastatic cancers will be a driving force for the expansion of the metastatic cancer drugs market. Metastatic cancer is a late-stage cancer that spreads across the body. As the number of metastatic cancer cases escalates, so does the creation of innovative drugs to treat various kinds of metastatic cancers. The…
Prominent Metastatic Breast Cancer Treatment Market Trend for 2025: Advancements …
Which drivers are expected to have the greatest impact on the over the metastatic breast cancer treatment market's growth?
The increasing occurrence of breast cancer is anticipated to boost the progression of the metastatic breast cancer treatment market. Breast cancer is a form of the disease that originates in the breast cells and is caused by abnormal cell growth in the breast, leading to the formation of a tumor. This alteration…
Major Force in the Metastatic Bone Disease Market 2025: Impact Of Bone Cancer Pr …
How Will the Metastatic Bone Disease Market Grow, and What Is the Projected Market Size?
The market size for metastatic bone disease has seen considerable growth in recent years. There is an expected increase from $17.14 billion in 2024 to $18.88 billion in 2025, with a compound annual growth rate (CAGR) of 10.1%. The substantial growth during the historical period can be credited to factors like rising aging population, heightened cancer…
Combination Therapy Strategies for Metastatic Cancer
Metastatic cancer, where cancer cells spread from the primary tumor to distant organs, presents significant treatment challenges. Combination therapy strategies have emerged as a powerful approach to enhance treatment efficacy, overcome resistance, and improve patient outcomes in metastatic cancer.
Download Report:
https://www.kuickresearch.com/report-cancer-antibody-combinations-therapy-cancer-antibody-combination-monoclonal-antibodies-combination-drug-conjugate-antibodies-combination
One of the primary goals of combination therapy in metastatic cancer is to target both the primary tumor and metastatic sites. This comprehensive approach can improve overall disease control…
